CytoDyn CYDY
OTC CYDY
$0.23 -0.01 (-4.17%)
At close: Nov 10, 2026 · 4:00 PM EST

CytoDyn (CYDY) EV to EBITDA (2024 - 2025)

Updated

CytoDyn's EV to EBITDA came in at 40.93 for fiscal Q4 2025 (quarter ended May 31, 2025), down 3.9% from the prior quarter.

Analysis

CytoDyn (CYDY) EV to EBITDA (2024 - 2025) Analysis & Trends

Going back to fiscal Q1 2025, CytoDyn's EV to EBITDA data covers 4 quarters.

  • The five-year range for quarterly EV to EBITDA is 11.95 (fiscal Q2 2025) to 42.59 (fiscal Q3 2025).
  • Business Quant data shows CYDY's EV to EBITDA at 42.59 (Q3 2025), 11.95 (Q2 2025) and 16.10 (Q1 2025) in the three fiscal quarters before Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 CytoDyn 334.50 Mn 285.65 Mn -
Historic Data

Historic Data

Download Data
DateValue
May 31, 2025 40.93
Feb 28, 2025 42.59
Nov 30, 2024 11.95
Aug 31, 2024 16.10
API Access

CytoDyn EV to EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=CYDY&period=max&api_key=YOUR_API_KEY